XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive loss
Accumulated Deficit
Series A-1 Redeemable Convertible Preferred Stock
Series A-2 Redeemable Convertible Preferred Stock
Series B Redeemable Convertible Preferred Stock
Beginning Balance at Dec. 31, 2020 $ (59,065) $ 1 $ 2,158   $ (61,224)      
Beginning Balance, Shares at Dec. 31, 2020   505,074            
Beginning Balance at Dec. 31, 2020           $ 2 $ 42,786 $ 64,548
Beginning Balance, Shares at Dec. 31, 2020           20,000,000 107,194,866 124,519,220
Issuance of redeemable convertible preferred stock               $ 45,375
Issuance of redeemable convertible preferred stock, Shares               87,259,605
Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering           $ (2) $ (42,786) $ (109,923)
Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering, Shares           (20,000,000) (107,194,866) (211,778,825)
Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering 152,711 $ 2 152,709          
Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering, Shares   24,924,501            
Issuance of common stock upon closing of initial public offering, net of offering costs and underwriter fees of $17,132 186,308 $ 1 186,307          
Issuance of common stock upon closing of initial public offering, net of offering costs and underwriter fees, Shares   11,302,219            
Issuance of common stock upon vesting and exercise of stock options 65   65          
Issuance of common stock upon vesting and exercise of stock options, Shares   38,216            
Stock-based compensation expense 891   891          
Net loss (13,723)       (13,723)      
Ending Balance at Mar. 31, 2021 267,187 $ 4 342,130   (74,947)      
Ending Balance, Shares at Mar. 31, 2021   36,770,010            
Beginning Balance at Dec. 31, 2020 (59,065) $ 1 2,158   (61,224)      
Beginning Balance, Shares at Dec. 31, 2020   505,074            
Beginning Balance at Dec. 31, 2020           $ 2 $ 42,786 $ 64,548
Beginning Balance, Shares at Dec. 31, 2020           20,000,000 107,194,866 124,519,220
Net loss (50,647)              
Ending Balance at Sep. 30, 2021 232,957 $ 4 344,824   (111,871)      
Ending Balance, Shares at Sep. 30, 2021   37,018,282            
Beginning Balance at Mar. 31, 2021 267,187 $ 4 342,130   (74,947)      
Beginning Balance, Shares at Mar. 31, 2021   36,770,010            
Issuance of common stock upon vesting and exercise of stock options 224   224          
Issuance of common stock upon vesting and exercise of stock options, Shares   115,362            
Stock-based compensation expense 1,067   1,067          
Net loss (18,370)       (18,370)      
Ending Balance at Jun. 30, 2021 250,108 $ 4 343,421   (93,317)      
Ending Balance, Shares at Jun. 30, 2021   36,885,372            
Issuance of common stock upon vesting and exercise of stock options 249   249          
Issuance of common stock upon vesting and exercise of stock options, Shares   132,910            
Stock-based compensation expense 1,154   1,154          
Net loss (18,554)       (18,554)      
Ending Balance at Sep. 30, 2021 232,957 $ 4 344,824   (111,871)      
Ending Balance, Shares at Sep. 30, 2021   37,018,282            
Beginning Balance at Dec. 31, 2021 $ 216,263 $ 4 346,382 $ 0 (130,123)      
Beginning Balance, Shares at Dec. 31, 2021 37,174,741 37,174,741            
Issuance of common stock upon vesting and exercise of stock options $ 247   247          
Issuance of common stock upon vesting and exercise of stock options, Shares   161,573            
Stock-based compensation expense 1,746   1,746          
Other comprehensive loss (1,072)     (1,072)        
Net loss (22,737)       (22,737)      
Ending Balance at Mar. 31, 2022 194,447 $ 4 348,375 (1,072) (152,860)      
Ending Balance, Shares at Mar. 31, 2022   37,336,314            
Beginning Balance at Dec. 31, 2021 $ 216,263 $ 4 346,382 0 (130,123)      
Beginning Balance, Shares at Dec. 31, 2021 37,174,741 37,174,741            
Other comprehensive loss $ (1,178)              
Net loss (68,184)              
Ending Balance at Sep. 30, 2022 $ 158,734 $ 4 358,215 (1,178) (198,307)      
Ending Balance, Shares at Sep. 30, 2022 38,393,211 38,393,211            
Beginning Balance at Mar. 31, 2022 $ 194,447 $ 4 348,375 (1,072) (152,860)      
Beginning Balance, Shares at Mar. 31, 2022   37,336,314            
Issuance of common stock upon vesting and exercise of stock options 146   146          
Issuance of common stock upon vesting and exercise of stock options, Shares   74,358            
Issuance of common stock from open market sales agreeement 553   553          
Issuance of common stock from open market sales agreeement, Shares   95,564            
Stock-based compensation expense 1,741   1,741          
Other comprehensive loss (254)     (254)        
Net loss (21,659)       (21,659)      
Ending Balance at Jun. 30, 2022 174,974 $ 4 350,815 (1,326) (174,519)      
Ending Balance, Shares at Jun. 30, 2022   37,506,236            
Issuance of common stock upon vesting and exercise of stock options 279   279          
Issuance of common stock upon vesting and exercise of stock options, Shares   126,509            
Issuance of common stock from open market sales agreeement 3,792   3,792          
Issuance of common stock from open market sales agreeement, Shares   760,466            
Stock-based compensation expense 3,329   3,329          
Other comprehensive loss 148     148        
Net loss (23,788)       (23,788)      
Ending Balance at Sep. 30, 2022 $ 158,734 $ 4 $ 358,215 $ (1,178) $ (198,307)      
Ending Balance, Shares at Sep. 30, 2022 38,393,211 38,393,211